Literature DB >> 1572102

Relationship between a novel human cytotoxin (factor 2) produced by a B cell line (Karpas 160) and phorbol-myristate-acetate-associated cytotoxicity.

J Ni1, A Karpas.   

Abstract

We found that 160b cells, a subclone of Karpas 160 human B cell line, spontaneously secreted a novel cytotoxin, factor 2 (F2). F2 was also extracted from the cells by 60% ammonium sulphate, 0.5% CHAPS and 0.28% Triton X-114. We were able to show that phorbol myristate acetate (PMA) greatly enhanced the production of F2, and PMA may also account for part of the putative F2 cytotoxic activity to K562 cells in crude preparations. We compared the cytotoxic effect of F2 with PMA-associated F2-like cytotoxicity to K562 cells as well as the adequacy of our schemes to purified F2 with regard to its separation from PMA. We found that it was possible to separate PMA from F2 preparations by gel filtration and Rotofor preparative isoelectric focusing. The fate of PMA was also monitored with 3H-PMA and chromatographic profiles of 3H-PMA were studied using DE52 and gel filtration chromatography. We were able to establish that less than 2.9% of the cytotoxicity to K562 was due to PMA. We also found that the radioactive peaks and cytotoxicity peaks to K562 were not well correlated, indicating that the cytotoxicity was not mainly due to remaining PMA. Activated charcoal removed virtually all F2 and PMA but not tumour necrosis factor activity. Our results also showed that cytotoxicity to K562 resulting from F2 or PMA-associated proteins had different physicochemical properties, indicating that they are different molecular entities. These findings are consistent with the earlier observation that 160 cells produce F2 spontaneously and that PMA can amplify its production significantly.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572102      PMCID: PMC1554294          DOI: 10.1111/j.1365-2249.1992.tb03088.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.

Authors:  J R Ortaldo; J R Ransom; T J Sayers; R B Herberman
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

2.  Analysis of a cytostatic lymphokine produced by incubation of lymphocytes with tumor cells: relationship to leukoregulin and distinction from recombinant lymphotoxin, recombinant tumor necrosis factor, and natural killer cytotoxic factor.

Authors:  T J Sayers; J H Ransom; A C Denn; R B Herberman; J R Ortaldo
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

3.  Identity of human B-cell line cytotoxic lymphokine with tumor necrosis factor type beta.

Authors:  H I Yamanaka; A Karpas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Murine interleukin 1.

Authors:  M Dukovich; S B Mizel
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

5.  Human lymphotoxin.

Authors:  B B Aggarwal
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

6.  Simultaneous production of natural human tumor necrosis factor-alpha, -beta and interferon-alpha from BALL-1 cells stimulated by HVJ.

Authors:  S Fukuda; S Ando; O Sanou; M Taniai; M Fujii; N Masaki; K Nakamura; O Ando; K Torigoe; T Sugimoto
Journal:  Lymphokine Res       Date:  1988

7.  Antigen-independent activation of cytotoxic T cells by lymphokines.

Authors:  L D Williams; W R McMaster; H S Teh
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

8.  Transferrin receptor and 4F2 expression by NK-sensitive and NK-resistant tumour cell lines.

Authors:  M J Zanyk; D Banerjee; D L McFarlane
Journal:  Carcinogenesis       Date:  1988-08       Impact factor: 4.944

9.  Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.

Authors:  J R Ortaldo; R Winkler-Pickett; A C Morgan; C Woodhouse; R Kantor; C W Reynolds
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

10.  A human haemic cell line capable of cellular and humoral killing of normal and malignant cells.

Authors:  A Karpas
Journal:  Br J Cancer       Date:  1977-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.